Dow Up0.51% Nasdaq Up0.24%

Rockwell Medical, Inc. (RMTI)

9.01 Up 0.10(1.12%) Nov 21, 4:00PM EST
|After Hours : 9.01 Up 0.00 (0.01%) Nov 21, 4:45PM EST
ProfileGet Profile for:
Rockwell Medical, Inc.
30142 Wixom Road
Wixom, MI 48393
United States - Map
Phone: 248-960-9009
Fax: 248-960-9119

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:286

Business Summary 

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. It offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis. The company’s products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. Its lead drug candidates include Triferic, which is in late-stage clinical development for the treatment of iron replacement in dialysis patients; and Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. The company also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Rockwell Medical, Inc.

Corporate Governance 
Rockwell Medical, Inc.’s ISS Governance QuickScore as of Nov 1, 2014 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 6; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Robert L. Chioini , 49
Founder, Chairman, Chief Exec. Officer, Pres and Member of Stock Option Committee
Mr. Thomas E. Klema CPA, MBA, 60
Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec. and Treasurer
Dr. Ajay Gupta M.D., 56
Chief Scientific Officer and Member of Scientific Advisory Board
Dr. Raymond Dennis Pratt M.D., FACP, 63
Chief Medical Officer
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders